Study S002673

PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04856683
Acronym: PROMETEO
Study type: OBSERVATIONAL
Status: UNKNOWN
Enrollment: 1100
Start: 2020-08-10
Primary completion: 2023-08
Lead sponsor: University of Roma La Sapienza
Conditions: Frailty
Results posted: FALSE

Registered primary outcomes

Composite Clinical Score [Baseline]
Prediction of frailty [Baseline]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.